Among 200 dialysis patients, 37% were non-compliant with their phosphate binders compared with 12% to 18% of patients who ...

Virtual investor event to be held on Tuesday April 29, 2025, at 8 a.m. ET ...

Official Digital Poster of the 50th International Exhibition of Inventions Geneva (IEIG) (Photo reference:  The Department of Science and Technology showcases a diverse lineup of technologies to ...

Dendi, a leading cloud-native laboratory information system (LIS) provider, is excited to announce a strategic partnership with Molecular Lab Partners (MLP), a consultancy specializing in fast and ...

Catherine Tingelstad has brought her passion for teaching to Charlotte students and colleagues, creating a dynamic and engaging learning environment that fosters growth and success after experiencing ...

Three Gallaudet Biology students won honors and cash prizes in this year's NASA DC Space Grant Consortium’s student poster ...

Poster E0055: High-dose isavuconazole therapy is well-tolerated and significantly improves survival in a fruit fly model of invasive mucormycosis – S. Wurster, N. D. Albert, N. P. Wiederhold, R. E.

Erleada reduced the risk of death by more than 20% compared with other treatments in metastatic castration-sensitive prostate ...

In the European Union (EU), lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and mild dementia due to Alzheimer’s disease (early ...

Pancreatic cancer is one of the most aggressive cancers and has one of the lowest survival rates-only 10% after five years.

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. announced today that the European Commission (EC) has granted the amyloid-beta (A?) monoclonal antibody Leqembi® ...

Galderma Launches Sculptra® in China, Further Fueling Its Growth Into One of the Fastest Growing Aesthetics Markets ...